🇺🇸 US

ARWR earnings report dates and EPS history (Arrowhead Pharmaceuticals, Inc.)

Quick answer

Arrowhead Pharmaceuticals, Inc. (ARWR) reported diluted EPS of $-1.36 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-08-04. Its last four 10-Q/10-K filings were on 2026-08-04, 2026-05-07, 2026-02-05, 2025-11-25.

✓ SEC EDGAR XBRL company facts (10-K/10-Q filings)

Data as of 2026-08-04. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)

Period endPeriodFormSEC filing dateDiluted EPS
2026-06-30Quarter10-Q2026-08-04$-1.36
2026-03-31Quarter10-Q2026-05-07$-0.93
2025-12-31Quarter10-Q2026-02-05$0.22
2025-09-30Full year10-K2025-11-25$-0.01
2025-06-30Quarter10-Q2025-08-07$-1.26
2025-03-31Quarter10-Q2025-05-12$2.75
2024-12-31Quarter10-Q2025-02-10$-1.39
2024-09-30Full year10-K2024-11-26$-5.00
2024-06-30Quarter10-Q2024-08-08$-1.38
2024-03-31Quarter10-Q2024-05-09$-1.02
2023-12-31Quarter10-Q2024-02-06$-1.24
2023-09-30Full year10-K2023-11-29$-1.92
2023-06-30Quarter10-Q2023-08-07$-0.96
2023-03-31Quarter10-Q2023-05-02$0.45
2022-12-31Quarter10-Q2023-02-06$-0.39
2022-09-30Full year10-K2022-11-28$-1.67

Related

Last updated 2026-10-16. Data only, not financial or tax advice.